Template:Butalbital/aspirin/caffeine: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Blanked the page)
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
 
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Butalbital/aspirin/caffeine|{{fontcolor|#6C7B8B|Butalbital/aspirin/caffeine }}]]'''''
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup<sup>®</sup> FDA Package Insert
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup indications and usage|Indications and Usage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup dosage forms and strengths|Dosage Forms and Strengths]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup contraindications|Contraindications]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup warnings and precautions|Warnings and Precautions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup adverse reactions|Adverse Reactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup drug interactions|Drug Interactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup use in specific populations|Use in Specific Populations]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup description|Description]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup clinical pharmacology|Clinical Pharmacology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup clinical studies|Clinical Studies]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup how supplied storage and handling|How Supplied/Storage and Handling]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup patient counseling information|Patient Counseling Information]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet<sup>®</sup> FDA Package Insert
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet indications and usage|Indications and Usage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet dosage forms and strengths|Dosage Forms and Strengths]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet contraindications|Contraindications]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet warnings and precautions|Warnings and Precautions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet adverse reactions|Adverse Reactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet drug interactions|Drug Interactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet use in specific populations|Use in Specific Populations]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet description|Description]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet clinical pharmacology|Clinical Pharmacology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet clinical studies|Clinical Studies]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet how supplied storage and handling|How Supplied/Storage and Handling]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet patient counseling information|Patient Counseling Information]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|}

Revision as of 00:16, 12 February 2014